Category: Latest News
-
Bank of America Maintains Buy Rating on Micron Following Memory Supply and Technology Updates
Bank of America has maintained its buy rating on Micron Technology (NASDAQ:MU) following meetings with company executives, citing developments in memory supply agreements, manufacturing technology and the company’s product roadmap through 2027 and 2028. The bank’s analysts met with Micron management in New York and Boston last week, following the semiconductor manufacturer’s recent technology and…
-
C.H. Robinson Expands AI Automation to Ocean Freight, Air Cargo and Customs Brokerage
C.H. Robinson (NASDAQ:CHRW) has introduced additional artificial intelligence agents for ocean freight, air cargo and customs brokerage, extending its automation technology into more areas of international freight forwarding. The logistics company said the new systems support freight pricing, ocean shipment bookings and customs documentation, building on its existing AI capabilities under a strategy it refers…
-
Quantum X Labs Begins Quantum Error Correction Experiments at Israeli Computing Centre
Quantum X Labs Inc. (USOTC:QUTX) has initiated a quantum error correction research programme using the Arbel superconducting quantum processor at the Israeli Quantum Computing Center (IQCC), according to a company announcement. The facility is operated by Quantum Machines and provides the hardware environment for Quantum X Labs to conduct experiments involving quantum processor performance, control…
-
Honeywell Deploys Industrial AI Platform at Dangote Refinery in Nigeria
Honeywell Technologies (NASDAQ:HON) has launched Forge Plant Cognition, an artificial intelligence platform designed for industrial operations, with its first deployment at Dangote’s petroleum refinery in Lekki, Nigeria. The platform combines Honeywell’s industrial technology with AI and accelerated computing capabilities from NVIDIA (NASDAQ:NVDA) and infrastructure supplied by Dell Technologies (NYSE:DELL). According to Honeywell, the system is…
-
Meta Shares Recover as Company Announces $35 Billion AI Financing Plan
Meta Platforms (NASDAQ:META) shares recovered from earlier losses to trade 1% higher after the company announced approximately $35 billion in equity offerings to support its artificial intelligence infrastructure investments. The stock had fallen as much as 4% earlier in the session as investors assessed the proposed fundraising and its potential implications for existing shareholders. The…
-
Verizon Beats Third-Quarter Profit Estimates and Raises 2026 Earnings Guidance
Verizon Communications (NYSE:VZ) reported third-quarter 2026 adjusted earnings above analysts’ expectations on Monday and increased its full-year guidance following growth in mobile phone subscribers, service revenue and cash flow. The US telecommunications company reported adjusted earnings per share of $1.31, exceeding the analyst consensus of $1.28 by $0.03. Quarterly revenue increased 1.5% year on year…
-
Anthropic Files for Nasdaq IPO as Revenue Reaches $16.3 Billion and Valuation Could Approach $2 Trillion
Artificial intelligence developer Anthropic publicly filed for an initial public offering on Monday, seeking to list its shares on the Nasdaq under the proposed ticker ANT, after reporting a substantial increase in revenue alongside significant losses and long-term computing infrastructure commitments. The company has appointed Goldman Sachs and Morgan Stanley to lead the offering but…
-
Wall Street Futures Rise as Oil Prices Fall Ahead of Fed Decision and Technology Earnings: Dow Jones, S&P, Nasdaq
US stock index futures pointed to a higher opening on Monday, indicating a possible recovery following two consecutive sessions of declines on Wall Street, as falling oil prices provided some relief ahead of the Federal Reserve’s interest rate decision and quarterly earnings from major technology companies. The anticipated rebound follows losses that pushed the Nasdaq…
-
Novartis Reports Lower Relapse Rates and No Hy’s Law Cases in Phase 3 Remibrutinib MS Trials
Novartis (NYSE:NVS) reported that its experimental multiple sclerosis treatment remibrutinib reduced annualised relapse rates by more than 30% compared with Sanofi’s Aubagio (teriflunomide) in two Phase 3 clinical trials, with no cases of Hy’s Law liver injury identified among patients receiving the investigational drug. Shares in the Swiss pharmaceutical company declined on Monday following the…
-
Surgery Partners Shares Rise More Than 21% Premarket Following Reported $6 Billion Bon Secours Deal
Surgery Partners (NASDAQ:SGRY) shares rose more than 21% in premarket trading on Monday following a Financial Times report that the US surgical care provider had agreed to be taken private by Bon Secours Mercy Health in a transaction valued at approximately $6 billion, including debt. According to the report, which cited people familiar with the…